Eclampsia : before and after magnesium sulphate.

Simple item page
dc.contributor.authorChaudhary, Pen_US
dc.date.accessioned2009-05-28T03:44:56Z
dc.date.available2009-05-28T03:44:56Z
dc.date.issued2006-06-06en_US
dc.description.abstractThis study was done to see the incidence and impact of changes in the intervention strategy for the management of eclampsia in a maternity hospital on maternal and perinatal outcome. Analysis of case records of all eclampsia cases over two different study periods designated as study period A (April, 1994 to Oct, 1996) and study period B (April, 2000 to April, 2001) were done. Total number of eclampsia cases who received intervention over two different study period (46 in study period A and 47 in study period B) were comparable despite the difference in the duration of study period. During study period A, diazepam was used as anticonvulsant, whereas magnesium sulphate was used to control fits during study period B. Incidence of eclampsia has markedly increased in this hospital (0.12% vs 0.29%). Epidemiology and clinical profile of eclamptic patients do not show remarkable change. There was no maternal death in study period B (April, 2000 to April, 2001) whereas there was one maternal death in the study period A (April, 1994 to October, 1996). Marked improvement was noticed in terms of recurrence of fit (19.13% vs 73.91%) with change in the intervention strategy. Perinatal deaths were fewer in study period B (20% vs 33%). Overall, it seems that care of eclamptic patients and use of magnesium sulphate as anticonvulsant has resulted in positive impact on maternal outcome.en_US
dc.description.affiliationMaternity Hospital, Thapathali, Kathmandu, Nepal.en_US
dc.identifier.citationChaudhary P. Eclampsia : before and after magnesium sulphate. Journal of the Nepal Medical Association. 2005 Oct-Dec; 44(160): 124-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/45901
dc.language.isoengen_US
dc.source.urihttps://www.jnma.com.np/en_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAnticonvulsants --therapeutic useen_US
dc.subject.meshDiazepam --therapeutic useen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshEclampsia --drug therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHospitals, Maternity --statistics & numerical dataen_US
dc.subject.meshHumansen_US
dc.subject.meshMagnesium Sulfate --therapeutic useen_US
dc.subject.meshNepal --epidemiologyen_US
dc.subject.meshNifedipine --therapeutic useen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPremature Birth --epidemiologyen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshStillbirth --epidemiologyen_US
dc.subject.meshTocolytic Agents --therapeutic useen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleEclampsia : before and after magnesium sulphate.en_US
dc.typeComparative Studyen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Nepal Medical Association